215 related articles for article (PubMed ID: 17071074)
1. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
Butcher DT; Rodenhiser DI
Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Green AR; Krivinskas S; Young P; Rakha EA; Paish EC; Powe DG; Ellis IO
Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
[TBL] [Abstract][Full Text] [Related]
4. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
5. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of the ZBRK1 gene in human breast carcinomas.
Garcia V; Domínguez G; García JM; Silva J; Peña C; Silva JM; Carcereny E; Menendez J; España P; Bonilla F
J Pathol; 2004 Feb; 202(2):224-32. PubMed ID: 14743505
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
10. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
Rakha EA; Pinder SE; Paish CE; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1591-6. PubMed ID: 15354217
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic A; Simpfendorfer D
Cancer Res; 1997 Aug; 57(16):3347-50. PubMed ID: 9269993
[TBL] [Abstract][Full Text] [Related]
13. [Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer].
Liu Z; Yang L; Cui DX; Liu BL; Zhang XB; Ma WF; Zhang Q
Ai Zheng; 2007 Jun; 26(6):586-90. PubMed ID: 17562262
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
[TBL] [Abstract][Full Text] [Related]
15. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
Wang JX; Zhang YG; Zhao LS
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
17. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]